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Low-intensity, low-frequency ultrasound (LILFU) is
the next-generation, non-invasive brain stimulation
technology for treating various neurological and psy-
chiatric disorders. However, the underlying cellular
and molecular mechanism of LILFU-induced neuro-
modulation has remained unknown. Here, we report
that LILFU-induced neuromodulation is initiated by
opening of TRPA1 channels in astrocytes. The Ca2+
entry through TRPA1 causes a release of gliotrans-
mitters including glutamate through Best1 channels
in astrocytes. The released glutamate activates
NMDA receptors in neighboring neurons to elicit
action potential firing. Our results reveal an unprece-
dented mechanism of LILFU-induced neuromodula-
tion, involving TRPA1 as a unique sensor for LILFU
and glutamate-releasing Best1 as a mediator of
glia-neuron interaction. These discoveries should
prove to be useful for optimization of human brain
stimulation and ultrasonogenetic manipulations of
TRPA1.
INTRODUCTION
Neuromodulation is defined as the alteration of neuronal activity
through targeted delivery of a stimulus to specific brain regions.
Neuromodulation has substantial relevance not only for the3386 Current Biology 29, 3386–3401, October 21, 2019 ª 2019 Elsevtreatment of neurological and psychiatric disorders, such as Alz-
heimer’s disease, Parkinson’s disease, depression, epilepsy,
and chronic pain [1–5], but also for elucidation of how the brain
functions during sensory, motor, and cognitive processes. The
most commonly employed techniques for neuromodulation
and brain stimulation include deep brain stimulation, transcranial
magnetic stimulation, transcranial direct current stimulation, and
optogenetic and chemogenetic approaches [6]. However, each
of these approaches carries serious limitations for human appli-
cations. For example, deep brain stimulation requires surgical
implantation of stimulating electrode, transcranial magnetic
stimulation and transcranial direct current stimulation offer
poor spatial resolution, and optogenetic and chemogenetic ap-
proaches require genetic manipulations [6].
Low-intensity, low-frequency ultrasound (LILFU) has been
considered to be the next-generation, non-invasive brain stimu-
lation technology [7]. The advantages of LILFU have been
described [6] as its non-invasive nature, high spatial resolution,
deep penetration, combinational use with MRI, cost-effective
implementation, and long-lasting neuromodulatory effect
without noticeable side effects when the non-thermal power
levels range from 30 to 500 mW/cm2 at the frequency of less
than 1 MHz [8]. Reports spanning more than a half century
have demonstrated that ultrasound can modulate neuronal ac-
tivity in vitro and ex vivo [8, 9]. In recent years, the neuromodula-
tory effects of LILFU have been reported in multiple animal
models in vivo [10–13] and in human [14, 15].
Although potential mechanisms underlying ultrasonic neuro-
modulation have been suggested by many studies [6, 16, 17],
the precise cellular target and molecular sensor for LILFU haveier Ltd.
remained enigmatic. It has been generally proposed that activa-
tion of mechanosensitive channels is one of the potential mech-
anisms of the ultrasonic neuromodulation. Previous reports
describe that Piezo [18], Nav1.5 [19], and K2P, including
TREK-1, TREK-2, and TRAAK [19], can be activated by high-in-
tensity, high-frequency ultrasonic stimulation. However, it is un-
clear whether thosemechanosensitive channels (Piezo1, Nav1.5,
TREK-1, TREK-2, and TRAAK) can be activated by LILFU. Thus,
the search for the identity of LILFU-sensing mechanosensitive
channel in the brain continues.
TRPA1, a member of the transient receptor potential (TRP)
family, has been actively investigated in the peripheral nocicep-
tor sensory neurons in terms of its function in mechanotransduc-
tion [20–23]. In the central nervous system, it has been recently
reported that TRPA1 is expressed in astrocytes of the hippocam-
pus, cortex, and trigeminal caudal nucleus [24–29], functioning
as a regulator of resting Ca2+ level [24, 26]. However, until
now, there has been no report about TRPA1 functioning as a
sensor for LILFU in the central nervous system. In this study, us-
ing the cell-type-specific gene-silencing and ultrasensitive
sniffer-patch techniques, we have identified astrocyte as the
cellular target and TRPA1 as the molecular sensor for LILFU.
RESULTS
TRPA1 Mediates LILFU-Induced Neuromodulation and
Motor Behavior
Transcranial LILFU-stimulated neuronal activity in motor cortex is
known to be sufficient to elicit motor behaviors, such as tail move-
ment in mice [12, 30]. As LILFU was shown to induce Ca2+
responses in both neurons and astrocytes [8] by exerting a me-
chanical pressure wave onto plasma membrane, we screened
for candidate mechanosensitive Ca2+ channels, such as TRPA1
as a molecular target for LILFU-induced neuromodulation. Thus,
we first stimulated the motor cortex in vivo of wild-type (WT) and
TRPA1 knockout (KO) mice by transcranial LILFU (Figure S1) and
checked the tail movement score (Figure 1A; Video S1) as previ-
ously described [31]. In both WT and TRPA1 KO, tail movement
was increased inan intensity-dependentmanner (Figure1B).How-
ever, tail movement in TRPA1 KO was significantly reduced
compared to WT (Figure 1B), suggesting that TRPA1 mediates
LILFU-induced neuromodulation and motor behavior. This differ-
ence between WT and TRPA1 KO is not due to an impaired audi-
tory system as recently reported [32, 33], because TRPA1 KO has
been demonstrated to be normal in hearing [20].
To determine whether TRPA1 has a critical role in LILFU-stim-
ulated neuronal activity, we measured LILFU-induced neuronal
firing in organotypic rat hippocampal slice culture by multielec-
trode array (MEA) recording (Figures 1C and S2), as we previ-
ously reported [9]. We first constructed lentivirus carrying small
hairpin-forming interference RNA (shRNA) targeted against
TRPA1 (Figures S3D–S3F). Then, we infected the hippocampal
CA1 of slice culture with lentivirus carrying control- or TRPA1-
shRNA and measured the CA1 pyramidal neuronal activity
upon LILFU (Figure 1D). We found that LILFU-induced neuronal
firing in TRPA1-shRNA-infected slice was significantly
decreased compared to that in control-shRNA-infected slice
(Figure 1E). These results indicate that the enhancement of
neuronal activity by LILFU could be mediated by TRPA1.We next asked whether TRPA1 is directly activated by LILFU.
We performed Ca2+ imaging to measure a LILFU-induced Ca2+
increase via TRPA1, which was heterologously expressed in
HEK293T. The functional expression of TRPA1 in HEK293T
was confirmed byN-methylmaleimide (NMM), a TRPA1 selective
agonist (Figures S3A–S3C). TRPA1-expressing cells were plated
onto a cover glass, which was placed on top of a custom-built
piezo-electric micromachined ultrasonic transducer (pMUT)
array (Figure 1F), whose physical properties were characterized
and described in our previous report [34]. As a result, LILFU-
induced Ca2+ increase in TRPA1-expressing HEK293T was
more frequently observed (Figures 1G and 1H) with significantly
higher peak amplitude compared to untransfected control (Fig-
ure 1I). These results show that LILFU can open TRPA1 to cause
intracellular Ca2+ increase.
We next checked other potential molecular sensor for LILFU,
such as TRPC1, TRPV4, and Piezo1, by measuring the LILFU-
induced Ca2+ increase in HEK293T with pMUT array (Figure 2A).
We found that LILFU did not induce appreciable Ca2+ increase in
TRPC1, TRPV4, or Piezo1-expressing HEK293T with signifi-
cantly lower peak amplitude and percentage of responsive cells
than TRPA1-overexpressing HEK293T (Figures 2B and 2C).
These results indicate that a well-known mechanosensitive
Piezo1 channel and other candidate mechanosensitive TRP
channels are not the molecular sensor for LILFU.
LILFU Activates Astrocytic TRPA1Directly andNeuronal
NMDAR Indirectly
To identify the cellular target of LILFU among neurons and as-
trocytes, we measured LILFU-induced Ca2+ increase in the
coculture of cortical neurons and astrocytes. We found 42%
of responsive cells, including neurons and astrocytes with vary-
ing degrees of onset time when we cultured WT neurons and
WT astrocytes (Figures 3A–3E). Most of the LILFU-induced
Ca2+ responses with either fast or slow onset were blocked
by HC030031, a selective TRPA1 blocker (Figures 3A–3C). To
test whether astrocytic TRPA1 is solely responsible for LILFU-
induced Ca2+ responses, we substituted WT astrocytes with
TRPA1 KO astrocytes, while leaving WT neurons behind. We
found a significant reduction of LILFU-induced Ca2+ increase
with either fast or slow onset in coculture of TRPA1 KO astro-
cytes and WT neurons (Figures 3A–3C), suggesting that astro-
cytic TRPA1 is solely responsible for LILFU-induced Ca2+
responses. We previously reported that Ca2+-dependent
release of glutamate from astrocytes can activate neuronal
NDMA receptors (NMDARs) [35–37]. To test whether the
LILFU-induced neuronal Ca2+ response is mediated by
NMDAR, we treated AP-5, an NMDAR selective antagonist, to
coculture of WT neurons and WT astrocytes. We found a selec-
tive reduction of slow-onset Ca2+ responses by AP-5 with only
fast-onset Ca2+ responses remaining (35%) (Figures 3A–3F).
Taken together, these results indicate that LILFU directly tar-
gets astrocytic TRPA1, causing the fast-onset Ca2+ responses
as an upstream signaling to elicit neuronal responses indirectly
via NMDARs with the slow-onset Ca2+ responses as a down-
stream signaling of LILFU.
To determine the astrocytic TRPA1 as a sensor for LILFU, we
prepared purified cortical astrocyte culture and measured the





Figure 1. TRPA1 Mediates LILFU-Induced Neuromodulation and Motor Behavior
(A) Schematic diagram of in vivo mouse tail movement test using ultrasound to motor cortex.
(B) Tail movement score of WT (n = 4) and TRPA1 KO (n = 7) under various intensities of ultrasound.
(C) Experimental setup of MEA recording with LILFU in organotypic rat hippocampal slice culture. Inset: representative bright field image of hippocampal slice
plated on MEA is shown.
(D) Representative traces of LILFU-induced neuronal activity from CA1 region of hippocampal slice infected with control-shRNA (top) and TRPA1-shRNA
(bottom).
(E) Summary bar graph showing the number of neuronal firings during 3-min LILFU as a percent of 3-min baseline before LILFU in control- and TRPA1-shRNA-
infected slice.
(F) Experimental setup of in vitro Ca2+ imaging upon LILFU. Inset: pMUT array. PCB, printed circuit board.
(G) Top: schematic diagram of Ca2+ imaging from HEK293T. Bottom: representative Ca2+ traces of untransfected control and TRPA1-expressing HEK293T upon
LILFU.
(H and I) Summary bar graph showing percent of responsive cells (H) and Ca2+ peak amplitude (I).
Number on each bar refers to the number of responsive cells over the number of total cells (H) and cells (I) analyzed. Speakers and waves indicate duration of
LILFU. Data are presented as mean ± SEM. **p < 0.01; ***p < 0.001; ****p < 0.0001; ns, not significant. Additional statistical details are provided in Table S1.
See also Figures S1, S2, and S3 and Video S1.most of the astrocytes responded to NMM, which was signifi-
cantly inhibited by expression of TRPA1-shRNA (Figures S3G–
S3I), indicating a functional expression of TRPA1 in astrocytes.
More importantly, LILFU activated astrocytic TRPA1 by eliciting3388 Current Biology 29, 3386–3401, October 21, 2019Ca2+ responses with fast onset (Video S2), which was signifi-
cantly inhibited by HC030031 (Figures 3G–3I) and TRPA1-
shRNA (Figures 3J–3L). These results confirm that astrocytic
TRPA1 serves as a potential molecular target for LILFU.
A
B C
Figure 2. Piezo1 and Other TRPs Do Not
Mediate LILFU-Induced Ca2+ Increases
(A) Top: schematic diagram of Ca2+ imaging from
HEK293T. Bottom: Representative Ca2+ traces of
control vector (pIRES2-EGFP), TRPA1, TRPC1,
TRPV4, or Piezo1-expressing HEK293T upon LILFU.
(B and C) Summary bar graph showing percent of
responsive cells (B) and Ca2+ peak amplitude (C).
Number on each bar refers to the number of
responsive cells over the number of total cells (B)
and cells (C) analyzed. Data are presented as
mean ± SEM. ****p < 0.0001. Additional statistical
details are provided in Table S1.
See also Figure S3.TRPA1, Possibly Activated by Poking, Causes Best1-
Mediated Glutamate Release from Astrocyte
To validate whether LILFU-induced Ca2+ increase is indeed
channel mediated, we tried to directly measure the channel ac-
tivity by TRPA1 upon LILFU. However, we encountered a diffi-
culty in measuring this current because LILFU disrupted the
whole-cell patch clamp. Thus, we changed the stimulation
strategy from LILFU to three different modes of mechanical stim-
ulations to mimic the LILFU. First, we tried to perform the piezo-
electrically driven fast-exerted mechanical stimulation (600 ms)
with varying indentation depths (1, 3, and 5 mm) under whole-
cell patch-clamp configuration (Figure 4A) as previously
described [38, 39]. We observed fast inactivating mechanosen-
sitive currents upon indentation in 33% of control-vector-ex-
pressing HEK293T, which had similar current amplitude and
percentage of cells with previous report [38] (Figures 4B and
4C), and no indentation-induced mechanosensitive currents
were observed in control-vector-expressing Piezo1 knockout
HEK293T (HEK-P1KO) (Figures 4B and 4C), due to an absence
of endogenous Piezo1 [38]. In contrast, most of TRPA1-express-
ing HEK293T did not show any indentation-induced currents
(Figures 4B and 4C). Even though 25% of TRPA1-expressing
HEK293T showed some distinct non-inactivating currents (Fig-
ures 4B, 4D, and 4E), these currents were entirely different
from the previously shown Piezo1-expressing HEK293T [38].
These results indicate that mechanical stimulation by fast-ex-
erted indentation is not an optimal mode of mechanical stimula-
tion to activate TRPA1.
As a secondmode ofmechanical stimulation, we tested a fast-
exerted negative pressure (500ms; 0 to60mmHg;D10mmHg)
under cell-attached configuration (Figures 4F–4I), as previously
described [40]. Unfortunately, we found no sign of negative pres-
sure-induced current upon stimulation (Figures 4G and 4I).
Instead, we observed stochastic opening of single-channel cur-
rents only in TRPA1-expressing cells (HEK293T or HEK-P1KO),


































haCurrent BioThese single-channel currents were
blocked by inclusion of HC030031 in
internal solution (Figures 4G and 4I), indi-
cating that these single-channel activities
were mediated by TRPA1. Detailed sin-
gle-channel analyses indicated that these
TRPA1-mediated, single-channel activities
showed unitary current of 7.48 ± 0.11 pA= 10) at holding potential of80mV, which could be converted
single-channel conductance of 87.7 ± 1.29 pS (n = 10). The
served single-channel conductance was similar with previ-
sly reported values for TRPA1 [41]. Moreover, the open prob-
ility had no significant difference in each negative pressure
imulation condition in HEK293T or HEK-P1KO (Figure 4H), indi-
ting that TRPA1 opens independently of fast-exerted negative
essure. These results indicate that mechanical stimulation by
st-exerted negative pressure is not an optimal mode of me-
anical stimulation to activate TRPA1.
Because the fast modes of mechanical stimulation were not
fective in activation of TRPA1, we developed and applied a
w slow mode of mechanical stimulation of slow-exerted
king with glass pipette (Figures 5A, 5B, and S4C), adopted
m our previous report [42]. To perform poking stimulation,
monitored both the indentation depth and the resistance in-
ease (DR) of the glass pipette as it touched and pressed the
ll membrane with periodic test pulses of 10 mV at 20 Hz (Fig-
es 5A, 5B, and S4A–S4D). We directly measured the current
m TRPA1-expressing HEK293T upon poking by performing
ole-cell patch clamp (Figure 5C). We found that poking
uced a large inward current in 88% of TRPA1-expressing
lls, whereas it did not induce any current in control vector or
her candidate mechanosensitive TRPs-expressing cells
igures 5D and 5E). These poking-induced currents were inde-
ndent of the recently characterized mechanosensitive Ca2+
annel Piezo1 [38, 40] (Figures S5A–S5F). To test whether as-
cytic TRPA1 can be activated by poking, we measured the
king-induced current from cultured cortical astrocytes (Fig-
e 5F). We discovered that poking elicited large and fast inward
rrents (average rise time 5.06 ± 0.66 ms; n = 13) in control-
RNA-transfected astrocytes, which were almost completely
olished in TRPA1-shRNA-transfected astrocytes (Figures 5G
d 5H). Furthermore, opening of TRPA1 by poking caused a
bust Ca2+ entry in those astrocytes (Figures S5G–S5I). It










Figure 3. LILFU Activates Astrocytic TRPA1 Directly and Neuronal NMDAR Indirectly
(A) Top: schematic diagram of Ca2+ imaging from astrocyte-neuron coculture. Bottom: representative Ca2+ traces from WT coculture (WT neurons and WT
astrocytes), WT coculture with HC030031 (40 mM) treatment, coculture of WT neurons and TRPA1 KO astrocytes, andWT coculture with AP-5 (50 mM) treatment.
(B) Summary bar graph showing percent of responsive cells.
(C) Summary bar graph of Ca2+ peak amplitude.
(D) Plot of Ca2+ response onset time versus peak amplitude in WT coculture (gray) and WT coculture with AP-5 (orange).
(E and F) Frequency histogram of the number of responsive cells in WT coculture (E) and WT coculture with AP-5 (F) with 20-s bin of Ca2+ response onset time.
(legend continued on next page)
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detects UV light by sensing the nucleophiles, such as H2O2
[43, 44]. However, our poking-induced responses were not due
to indirect activation of TRPA1 through H2O2 (Figures S5J–
S5L). These results indicate that TRPA1 can be activated by
slow-exerted poking as well as LILFU, implying that LILFU can
open TRPA1.
We have previously shown that astrocytes can release gluta-
mate upon an increase in intracellular Ca2+ concentration
through opening of glutamate-permeable, Ca2+-activated anion
channel, Best1 [45]. Therefore, to examine whether poking-
induced Ca2+ entry via TRPA1 causes glutamate release from
astrocytes, we performed sniffer-patch technique to detect
poking-induced glutamate release from astrocyte with a nearby
whole-cell, patch-clamped HEK293T expressing GluR1-L497Y
as a biosensor for glutamate (Figure 5I), as previously described
[42, 45]. We observed a large poking-induced sensor current
from the sensor cell along with a simultaneous Ca2+ increase in
control-shRNA-transfected astrocyte (Figures 5J–5L). This
poking-induced sensor current, as well as poking-induced
Ca2+ transient, was significantly reduced by TRPA1-shRNA
expression in astrocyte (Figures 5J–5L). To test whether
poking-induced glutamate release is mediated by Best1, we
performed the sniffer patch from Best1-shRNA-transfected as-
trocytes. We found that sensor current was abolished by
Best1-shRNA, and the Ca2+ transient was intact in Best1-
shRNA-transfected astrocytes (Figures 5J–5L). Taken together,
these results show that mechanical stimulation causes Best1-
mediated glutamate release from astrocyte and that Ca2+ entry
via TRPA1 is its upstream signal.
We have utilized poking stimulus to activate the same TRPA1
channel that LILFU targets. However, it has been unclear
whether these two seemingly different types of stimuli activate
TRPA1 at similar magnitude of pressure. To compare the LILFU-
and poking-induced pressure distribution on the surface of
astrocyte, we performed computational simulations of 3D
astrocytic membrane for LILFU (Figure 5M) and poking stimuli
(Figure 5N). The resulting instantaneous 3D surface pressure
distribution for LILFU showed a stochastic pressure distribution,
which was spread over the whole surface, fluctuating
from 30 kPa to +30 kPa (Figure 5M), whereas the result of
poking simulation showed a focused pressure distribution
around the center of the tip with maximal pressure of 7.2 kPa
(Figure 5N). To estimate the threshold pressure for TRPA1 chan-
nel activation, we first assumed that poking exerts a local
membrane indentation to cause a stretch to the local membrane
surface, which results in a maximal activation of nearby TRPA1
channels, as evidenced by a synchronized channel activation
with sustained, non-desensitizing kinetics (Figure 5G). In
contrast, LILFU exerts instantaneously fluctuating membrane(G) Top: schematic diagram of Ca2+ imaging from cultured cortical astrocytes. B
astrocytes upon LILFU.
(H and I) Summary bar graph showing percent of responsive cells (H) and Ca2+ p
(J) Top: schematic diagram of Ca2+ imaging from cultured cortical astrocytes. Bo
astrocytes upon LILFU.
(K and L) Summary bar graph showing percent of responsive cells (K) and Ca2+
Number on each bar refers to the number of responsive cells over the number of
mean ± SEM. **p < 0.01; ****p < 0.0001. Additional statistical details are provide
See also Figure S3 and Video S2.indentations that cause brief TRPA1 channel activations. Based
on these assumptions, we compared the average peak Ca2+ re-
sponses by ultrasound and poking, which were normalized by
the NMM-induced Ca2+ responses in each recording setup (Fig-
ure 5O). This comparison showed that the average LILFU-
induced Ca2+ response was 33% of the average poking-induced
Ca2+ response. We then plotted the frequency histogram of
pressure distribution of the membrane surface of a single astro-
cyte by LILFU stimulation (Figure 5P) and identified the minimum
pressure value (acoustic power), whose cumulative sum of
normalized frequency is 33% of total membrane surface (Fig-
ure 5P). We defined this minimal pressure value as the threshold
pressure for activation of TRPA1 channel by LILFU and esti-
mated it to be around ±8 kPa (Figure 5P). We made another
assumption that astrocytic membrane contains multiple caveoli
with membrane invaginations, where TRPA1 channels might be
located and anchored to actin filaments perhaps via the ankyrin
repeats [46, 47], which can be stretched upon LILFU or poking
stimuli to open each channel (Figure S6). It has been previously
reported that astrocyte membrane contains caveoli. Each cav-
eolae has a diameter of 80 nm, as previously described for
cultured rat cortical astrocyte [48]. In another study, the density
of caveoli was 17 per 1 mm2 in cat optic nerve astrocyte [49]. The
membrane stiffness of rat cortical astrocyte has been previously
reported to be around 3060 kPa at the age of 23 weeks [50].
Using this stiffness value, we simulated the astrocytic surface
with 0.75-mm indentation by poking and found the range of pres-
sure to be around 7.2 kPa near the center of the poking area (Fig-
ure 5N), where a maximal activation of TRPA1 is induced. This
value coincided well within the threshold pressure for channel
activation of 8 kPa, which we calculated from the LILFU stimula-
tion. Taken together, the simulation results strongly support the
similarity of the estimated pressure for TRPA1 activation be-
tween LILFU and poking stimuli.
Released Glutamate from Astrocyte upon LILFU Targets
Synaptic NMDAR to Elicit Neuromodulation
Astrocytes make close and intimate contacts with presynaptic
and postsynaptic synapses to form the tripartite synapses for
bidirectional communication with neighboring neurons [51, 52].
The astrocytic subcellular structure at this tripartite synapse is
called microdomain, which consists of a thin and long peripheral
process, contacting andwrapping around each synapse [51, 53].
We have previously shown that Best1 is localized in
microdomains at synaptic junctions [45, 54] and that Best1-
mediated Ca2+-dependent glutamate release specifically targets
synaptic NMDAR and modulates synaptic activity [36, 37].
To determine the precise subcellular localization of TRPA1
in vivo, we performed an electron microscopic examination ofottom: representative Ca2+ traces from naive and HC030031 (40 mM)-treated
eak amplitude (I).
ttom: representative Ca2+ traces from control- and TRPA1-shRNA-transfected
peak amplitude (L).
total cells (B, H, and K) and cells (C, I, and L) analyzed. Data are presented as
d in Table S1.





Figure 4. Fast-Exerted Indentation and Negative Pressure Are Not Optimal for TRPA1 Activation
(A) Schematic diagramof whole-cell patch-clamp recording upon fast-exerted indentation (600ms; 15 mm;D2 mm) fromHEK293T or HEK293T-Piezo1 knockout
(HEK-P1KO).
(B) Representative traces of current recording from control vector (left) or TRPA1 (middle)-expressing HEK293T or control vector-expressing HEK-P1KO (right)
upon fast-exerted indentation.
(C) Summary bar graph showing maximum current amplitude.
(D) Summary graph showing maximum current amplitude as a function of stimulus amplitude (indentation depth).
(E) Summary graph showing current amplitude at 600 ms after fast-exerted indentation as a function of stimulus amplitude (indentation depth).
(F) Schematic diagram of cell-attached patch-clamp recording upon fast-exerted negative pressure (500ms; 060mmHg; D10mmHg) fromHEK293T or HEK-
P1KO.
(G) Left: representative merged traces of current recording from TRPA1-expressing HEK293T with or without HC030031 and control vector-expressing HEK293T
upon fast-exerted negative pressure. Right: representative merged traces of channel current recording from TRPA1-expressing HEK-P1KO with or without
HC030031 and control vector-expressing HEK-P1KO upon fast-exerted negative pressure.
(H) Summary bar graph showing open probability from TRPA1-expressing HEK293T (n = 10) or HEK-P1KO (n = 8) at each negative pressure.
(legend continued on next page)
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immunogold-labeled TRPA1 in immunoperoxidase-labeled
GFP-positive profiles in hippocampal CA1 of GFAP-GFP mouse
(Figure 6A). We observed that gold particles representing TRPA1
were localized in GFP-positive astrocytes, but not in neurons
(Figure 6A). Within an astrocyte, the total number of gold parti-
cles for TRPA1 and membrane-bound gold particles for TRPA1
in microdomain were significantly higher than those in soma
and process (Figures 6B and 6C). These results indicate that
TRPA1 is preferentially localized at microdomains adjacent to
synapses where Best1 is also found.
To test whether LILFU-induced glutamate release via Best1
from astrocyte targets synaptic NMDAR to elicit neuronal activ-
ity, we measured the LILFU-induced neuronal firing in organo-
typic rat hippocampal slice culture under various conditions
with pharmacological treatments and genetic manipulations
(Figures 6D and 6E). We found that TRPA1 blocker (HC030031)
and Best1 blockers (niflumic acid and NPPB) abolished LILFU-
induced enhancement of neuronal activity (Figure 6E). More
importantly, NMDAR blockers (AP-5 and kynurenic acid) elimi-
nated LILFU-induced enhancement of neuronal firing (Figures
6D and 6E). These results indicate that LILFU-induced neuronal
activity is mediated by NMDAR. To determine whether astrocytic
TRPA1 and Best1 are responsible for LILFU-induced activation
of synaptic NMDAR, we performed astrocyte-specific gene
silencing [55] of TRPA1 or Best1 (Figure S7A).We infected hippo-
campal CA1 region of slice culture with lentivirus carrying
pSico-TRPA1 or Best1-shRNA-GFP and adeno-associated virus
(AAV) carrying GFAP-Cre-mCherry for astrocyte-specific gene
silencing of TRPA1 or Best1 (Figure S7B) and then measured
the neuronal activity. This astrocyte-specific gene-silencing
technique has been extensively tested in our previous paper
[56]. We found that gene silencing of TRPA1 or Best1 abolished
LILFU-induced enhancement of neuronal firing only when
TRPA1-shRNA or Best1-shRNA was combined with AAV car-
rying GFAP-Cre (Figures 6F and 6G). Finally, we stimulated the
mouse motor cortex in vivo by transcranial LILFU and tested
the tail movement in Best1 KO. As predicted, tail movement by
LILFU was dramatically reduced in Best1 KO compared to WT
in almost all intensity of LILFU (Figure 6H; Video S3), indicating
that Best1 majorly contributes to LILFU-induced neuromodula-
tion. This difference between WT and Best1 KO is not due to
impaired auditory system because Best1 KO appears to be
normal in hearing. Based on these results, we demonstrate
that LILFU activates astrocytic TRPA1 directly and glutamate-
releasing Best1 indirectly through Ca2+ to target synaptic
NMDAR, leading to neuronal firing (Figure 7).
DISCUSSION
To date, previous studies have suggested several mechanisms
of neuronal activity induced by non-thermogenic, low-intensity
ultrasound. As a possible mechanism of neuromodulation, it
has been proposed that the ultrasound causes acoustic(I) Left: representative traces of current recording from TRPA1-expressing HEK293
from TRPA1-expressing HEK-P1KO at each negative pressure. Right: represe
HC030031 in internal solution at each negative pressure. Blue shades indicate th
Number on each bar refers to the number of responsive cells over the number of t
statistical details are provided in Table S1.cavitation [17] or the formation of gas bubble [57], which could
elicit neuronal activity by mechanical forces. However, these
proposals have been challenged by the lack of evidence for
physical damage or morphological change after LILFU [6].
Another recent report suggested that ultrasonic neuromodula-
tion occurs via mechanical stretch of the lipid bilayer in neurons
[8]. However, there has been no direct evidence for the presence
of mechanosensitive ion channels in neurons that can be directly
activated by LILFU. Surprisingly, we have found the presence of
highly sensitive poking-activated channel in astrocytes, but not
in neurons, raising astrocytes as the cellular target for LILFU.
We have newly characterized the Ca2+-permeable TRPA1 as
the specific molecular sensor and transducer for LILFU. With
TRPA1’s unique co-localization and cooperation with the gluta-
mate-releasing Ca2+-activated Best1 at the microdomains of as-
trocytes, LILFU is capable of eliciting neuromodulation as a
consequence of neuronal NMDAR activation (Figure 7).
Our study is the first to identify themolecular sensor and trans-
ducer for LILFU in the mammalian brain. Even though several
studies have suggested other mechanosensitive channels,
those candidate channels have profoundly different channel
properties. For example, Prieto et al. [18] showed that mouse
Piezo1 can be activated by ultrasound in Chinese hamster ovary
(CHO) or HEK293 cells. However, they observed an activation of
Piezo1 by ultrasound stimulation at 43 MHz and 5090 W/cm2.
These parameters are far from generally defined LILFU of the
non-thermal power levels ranging from 30 to 500 mW/cm2 at
the frequency of less than 1 MHz [8]. We used LILFU at
430 KHz and 306.1 mW/cm2 for TRPA1 stimulation, which are
more than 100-fold different from Piezo1 stimulation. Moreover,
we have directly demonstrated that our LILFU stimulation did
not cause an appreciable response in Piezo1-expressing
HEK293T (Figure 2). Kubanek et al. [19] also showed that
NaV1.5 channels and some K2P channels, including TREK-1,
TREK-2, and TRAAK, could be activated by focused ultrasound.
Again, the authors used focused ultrasound at 10 MHz and
0.34.9 W/cm2, which are also far from the defined parameters
of LILFU. Taken together, we can safely conclude that previously
suggested channels are unlikely to be a direct target of LILFU.
Although we have clearly demonstrated that TRPA1 is a
sensor for LILFU, whether TRPA1 is amechanosensitive channel
or not is still not clear. It was initially proposed that TRPA1 could
be a candidate for themechanosensitive transduction channel of
vertebrate hair cells [58]. However, the same authors disproved
their initial claim by demonstrating that TRPA1 is not essential for
hair cell transduction but directly or indirectly contributes to the
transduction of mechanical stimulus in nociceptor sensory neu-
rons [20]. In more recent reports, it has been shown that inden-
tation-induced, slowly adapting mechanosensitive currents in
smaller-diameter dorsal root ganglion (DRG) neurons are absent
in TRPA1 KO DRG neurons, indicating that those currents are
mediated by TRPA1 [21, 23]. However, both reports did not
clearly demonstrate whether TRPA1 is directly activated byT at each negative pressure.Middle: representative traces of current recording
ntative traces of current recording from TRPA1-expressing HEK-P1KO with
e duration of negative pressure (500 ms).
otal cells (C). Data are presented as mean ± SEM; ns, not significant. Additional
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membrane stretch or not. Thus, previous claims for TRPA1 as a
mechanosensitive channel are still premature. In our current
study, we have demonstrated that TRPA1 can be optimally acti-
vated by slow-exerted poking stimulation, but not by fast-ex-
erted indentation or negative pressure (Figures 4 and 5A–5L).
This provides supporting evidence for a possible activation of
TRPA1 by membrane stretch upon slow-exerted poking. More-
over, based on the assumption that TRPA1 is directly activated
by poking or LILFU, we performed computational simulations
to show that the estimated threshold pressure values for
TRPA1 activation by poking and LILFU were similar (Figures
5M–5P). These results imply that our assumption that TRPA1 is
directly activated by poking might be correct. Nevertheless,
there is still a possibility that TRPA1 could be indirectly activated
by unidentified factors upon membrane stretch. Although we
have demonstrated that H2O2, one of candidate factors for indi-
rect TRPA1 activation, is not involved in our poking-induced
TRPA1 activation (Figures S5J–S5L), there might be other un-
known factors that need further investigations. For more clear
demonstration of TRPA1 as a mechanosensitive channel, future
experiments are needed to demonstrate the activity of reconsti-
tuted TRPA1 in artificial lipid bilayer upon membrane stretch.
Based on the computational simulations of LILFU and poking
stimuli, we have obtained the precise pressure value of 8 kPa,
which is required for TRPA1 channel activation upon LILFU stim-
ulation. By obtaining this threshold pressure of TRPA1 channel
activation, we have provided supporting evidence for the long-
proposed involvement of a mechanosensitive channel and pres-
sure dependence of LILFU-induced neuromodulation [59]. For
the possible molecular mechanism of opening of TRPA1 channel
by mechanical stimulation, we further hypothesize that pressure
exerted on plasmamembrane causes themembrane stretch and
tension (Figure S6). TRPA1 has long 1618 ankyrin repeats in the
N-terminal region, which have been hypothesized to tether the
channel to cytoskeletal proteins and potentially act as a spring
that pulls the channels to open in response to extracellular force,
such as mechanical stress [46, 60]. The mechanical displace-
ment of actin filaments during cell stretch might be efficiently
increased in the presence of caveolae [61], which are the plasmaFigure 5. TRPA1, Activated by Poking, Elicits Glutamate Release from
(A) Schematic diagram showing the method of poking to the cell membrane of H
(B) Simultaneous recording of current generated by periodic test pulses of 10 m
recording pipette (red, bottom).
(C) Schematic diagram of whole-cell patch-clamp recording upon poking from H
(D) Representative traces of current recording from control vector, TRPA1, TRPC
(E) Summary bar graph showing current amplitude.
(F) Schematic diagram of whole-cell patch-clamp recording upon poking from c
(G) Representative traces of current recording from astrocytes transfected with c
(H) Summary bar graph showing current amplitude.
(I) Schematic diagram of sniffer-patch recording to detect released glutamate.
(J) Representative traces of Ca2+ imaging from astrocytes and sniffer current fro
transfected conditions.
(K and L) Summary bar graph of Ca2+ peak amplitude from astrocytes (K) and pe
(M and N) Computational simulation of pressure distribution in 3D astrocytic me
(O) Bar graph showing the average peak Ca2+ responses upon poking or LILFU. Pe
poking or LILFU experimental setup.
(P) The normalized frequency histogram of pressure distribution of the membran
Each diamond indicates time of poking. Data are presented as mean ± SEM. ***p
Number on each bar refers to the number of cells (O) analyzed. Additional statis
See also Figures S4, S5, and S6.membrane subdomains of distinct lipid and protein composi-
tions present in many mammalian cells, including astrocytes
[48, 49, 62, 63]. It is highly probable that TRPA1 channels might
reside in the pit of these caveoli, where the membrane stretch is
optimally transduced (Figure S6). Future investigations await for
this exciting possibility.
The astrocytic target of LILFU is an unexpected finding,
considering the fact that many investigators expected a mecha-
nism involving direct activation of neurons by LILFU [8, 17]. One
could still consider a possibility of an off-target effect of LILFU-
induced neuromodulation due to an expression of TRPA1 in
cell types other than astrocytes in the brain. However, this is un-
likely because there are numerous previous reports demon-
strating that TRPA1 is specifically expressed in astrocytes and
absent in neurons at least within the hippocampus [24, 26].
Consistently, we provide compelling lines of evidence of immu-
nogold electron microscopic results, demonstrating the exclu-
sive expression of TRPA1 in astrocytes, but not in neurons
(Figure 6A). Therefore, there should be minimal off-target effect
of LILFU-induced neuromodulation at least in the hippocampus,
indicating that LILFU-induced neuromodulation is mainly trig-
gered by TRPA1 in astrocytes. Future investigations are needed
to establish the cell-type-specific expression pattern of TRPA1 in
other brain regions.
One of the most puzzling aspects of LILFU technology is the
observed temporal delay for neuro-stimulation by ultrasound
[64, 65], which tends to be much slower than electrical and opti-
cal stimulation. Consistently, we observed that there is a tempo-
ral delay between the onset of LILFU and neuronal responses
(Figure S2). Our proposed mechanism can provide a plausible
explanation for this puzzle. The proposed model involves a
cascade of events that leads to spike firing (Figure 7); LILFU, as-
trocytic TRPA1 activation (Ca2+ increase), Ca2+-dependent
Best1 opening (glutamate release), diffusion of glutamate toward
neuronal NMDAR, glutamate binding to neuronal NMDAR and
relief of Mg2+ block, NMDAR channel opening and slow depolar-
ization, and depolarization-induced spike firing. This multistep
model contains a couple of steps that might delay the neuronal
response time. For example, although TRPA1 activation byAstrocyte via Best1
EK293T or astrocyte.
V at 20 Hz from poking pipette (blue, top) and poking-induced current from
EK293T.
1, or TRPV4-expressing HEK293T transfected with upon poking.
ultured cortical astrocytes.
ontrol- or TRPA1-shRNA upon poking.
m HEK293T sensor cells upon poking in control-, TRPA1-, or Best1-shRNA-
rcent of full activation from sensor cells (L).
mbrane for LILFU (M) and poking (N) stimuli with lookup table.
ak Ca2+ responses were normalized by NMM-induced Ca2+ responses in each
e surface of a single astrocyte from (M).
< 0.001; ****p < 0.0001; ns, not significant. Data are presented as mean ± SEM.
tical details are provided in Table S1.
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Figure 7. Schematic Model for LILFU-
Induced Neuromodulation
LILFU induces Ca2+ increase in astrocytes by
activation of TRPA1 and glutamate release from
astrocytes via Best1. The released glutamate
leads to increase of neuronal Ca2+ and firing by
activating NMDAR, resulting in synaptic plasticity
and behavior.poking is quite fast once it reaches the threshold of membrane
stretch or tension (average rise time 5.06 ± 0.66 ms; n = 13; Fig-
ure 5G), it takes some time (average onset time for LILFU-
induced Ca2+ responses: 1.35 ± 0.34 s; n = 53; Figure 3F) for
themembrane stretch or tension by LILFU to reach the threshold
for channel opening in cultured astrocytes. Another possible
time delay could come from the step in which glutamate-bound
NMDARs experience the relief of Mg2+ block due to a slow
regenerative depolarization by its own channel openings. Due
to its negative conductance at the negative potentials
(below 30 mV) in current-voltage relationship, NMDARs can
cause regenerative channel opening and depolarization, simi-
larly to the voltage-gated sodium channels. When neurons are
at rest, the resting membrane potential is around 60 mV and
the potential needs to reach around 35 mV to initiate an action
potential. It would take opening of some number of NMDARs and
100s of millisecond to depolarize from 60 mV to 35 mV. This
delay by NMDARs would further slow the spike firing onset time.
Taken together, our proposed model is consistent with the
observed delay in LILFU-induced neuronal firing.
The preferential activation of NMDAR over other glutamate
receptors by LILFU stimulation has been predicted by theFigure 6. Released Glutamate from Astrocyte upon LILFU Targets Syn
(A) Electron micrographs showing immunogold staining for TRPA1 in GFAP-GFP
soma (top left), process (top right), andmicrodomain (bottom). Arrowheads indicat
stained astrocytes. Scale bar, 500 nm.
(B) Summary bar graph showing gold particle density for TRPA1 in soma, proce
(C) Proportion of gold particles located on or near the plasma membrane of the
(D) Representative traces of LILFU-induced neuronal firing from CA1 region of c
(E) Summary bar graph showing the number of neuronal firing during 3-min LILF
niflumic acid (100 mM), NPPB (100 mM), AP-5 (50 mM), or kynurenic acid (300 mM
(F) Representative traces of LILFU-induced neuronal activity from CA1 region in
GFAP-Cre infection.
(G) Summary bar graph showing the number of neuronal firing during 3-min LILF
(H) Tail movement score of WT (n = 4) and Best1 KO (n = 4) mice under various
Data are presented as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0




















LIaptic NMDAR to Elicit N
mouse hippocampus CA1
e TRPA1. Arrows indicate GF
ss, and microdomain.
total number of gold particle
ontrol (top) and AP-5 (bottom
U as a percent of 3-min bas
)-treated slices.
control- (top), TRPA1- (mid
U as a percent of 3-min bas
intensities of ultrasound.
.0001. Additional statistical
Current Bioloestimation of Best1-mediated glutamate
release in our previous report. Through
diffusion modeling, we previously esti-
mated that glutamate concentration for
the slow release through Best1 from a
single astrocyte is 0.9 mM at the target
receptor of the opposing neuronal mem-
brane [45]. From this value, we further
predicted that glutamate release through
Best1 will preferentially activate NMDAR,
but not other glutamate receptors, such
as AMPAR, mGluR, and KAR, accordingthe reported concentration-response relationship for each
tamate receptor [45]. Moreover, we have previously demon-
rated that Best1-mediated astrocytic glutamate release re-
lted in activation of GluN2A-containing NMDAR, but not other
tamate receptors, and subsequent NMDAR-dependent
tentiation of synaptic responses [37]. Because the concentra-
n of glutamate released through Best1 was much lower
05106 M) than that from presynaptically released gluta-
ate (103 M), this increase in synaptic glutamate levels by
st1 activation had no significant effect on other synaptic gluta-
ate receptors, such as AMPAR and KAR [37]. Therefore, there
a strong possibility that the concentration of released gluta-
ate by LILFU-TRPA1-Best1 pathway may not be sufficient to
tivate synaptic glutamate receptors other than NMDAR.
ally, it is unlikely that the released glutamate through Best1
tivates the synaptic AMPAR, which exhibits rapid and com-
ete desensitization within a few milliseconds when activated
glutamate [66]. Therefore, it is unlikely that other glutamate re-
ptors, such as AMPAR, are directly activated by Best1-medi-
ed glutamate upon LILFU.
We observed the long-lasting Ca2+ responses during
LFU stimulation in astrocyte (Figures 3G and 3J). Sucheuromodulation
region. TRPA1 channels are located in astrocytic
P.White dotted lines indicate immunoperoxidase-
s for TRPA1 in soma, process, and microdomain.
)-treated hippocampal slice.
eline before LILFU in control, HC030031 (40 mM),
dle), or Best1-shRNA (bottom)-infected slice with
eline before LILFU.
details are provided in Table S1.
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LILFU-induced, long-lasting Ca2+ responses could explain the
observed long-term effect of ultrasound stimulation, such as
alteration of extracellular evoked potentials in the rat dentate gy-
rus of hippocampus [67], in CA1 of hippocampus [68], and in frog
sciatic nerves [69]. In addition, ultrasound stimulation has been
shown to increase BDNF protein expression in mouse CA1 and
CA3 of hippocampus in vivo [12]. We have recently reported
that resting astrocytes transform into active astrocytes under
the conditions of non-aversive, environmentally beneficial stimu-
lations, such as high neuronal activities or exposure to enriched
environment, and that these active astrocytes show enhanced
proBDNF expression level [70]. Based on these previous reports,
we speculate that LILFU, as an environmentally beneficial stim-
ulation, might transform the resting astrocyte to active astrocyte
and enhance expression and release of proBDNF, which is a
critical factor for long-term plasticity. This LILFU-induced,
BDNF-dependent brain plasticity might require the long-lasting
Ca2+ responses via astrocytic TRPA1. This exciting possibility
needs future investigations.
We hypothesize that our suggested TRPA1-Best1-NMDAR
pathway can be expanded beyond the physiological conditions
to pathological conditions, such as concussion type of brain
injury. Concussion, also known as mild traumatic brain injury,
is typically defined as transient neurological dysfunction [71].
Previously, it has been reported that such concussion-type in-
juries cause a direct mechanical effect on the cells in the brain
[72, 73]. These injuries can lead to a cortical spreading depres-
sion, which is attributed to massive slow brain depolarizations
that interrupt local cortical function for periods of minutes to
hours [74, 75]. Astrocytes are known to play an important role
in this cortical spreading depression through their propagating
Ca2+waves [76, 77]. Based on these previous reports, we predict
that the TRPA1-Best1-NMDAR pathway might be an important
mechanism involved in initiation and propagation of cortical
spreading depression induced by concussion. During concus-
sion, astrocytes can be mechanically stimulated, initiating a
cascade of events: hyper-activation of astrocytic TRPA1;
increased intracellular Ca2+; excess amount of glutamate release
through Best1; over-stimulation of NMDAR; cortical spreading
depression; and excitotoxicity. Therefore, the possibility that
the TRPA1-Best1-NMDAR pathway might participate in patho-
physiological processes, such as brain injury, should be exam-
ined in the future.
In addition to the currently popular optogenetics and chemo-
genetics, the ultrasonogenetics using TRPA1 opens up new
avenues for cell-type-specific activation or inhibition and even
long-term plasticity when combined with other Ca2+-activated
channels or Ca2+-dependent signaling molecules. The insights
and tools that we have developed in this study should be useful
for future optimization of LILFU as one of the most non-invasive
and low-cost neuromodulatory methods for human.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals and housing
TRPA1 knockout (KO; B6;129P-Trpa1tm1Kykw/J, RRID: IMSR_JAX:006401) mice were purchased from Jackson Laboratory and gen-
otyped as previously described [20]. They were backcrossed with C57BL/6J mice (RRID: IMSR_JAX:000664) for more than 10 gen-
erations and were thought as congenic to C57BL/6J. Best1 KO (Best1tm1Lmar/Best1tm1Lmar, RRID: MGI:3797408) mice in genetic
background of BALB/c were used [78]. Both types of mice were maintained as heterozygotes and crossed to obtain null mutants
and wild-type (WT) littermates. hGFAP-GFP transgenic mice (RRID: IMSR_JAX:003257) were purchased from Jackson Laboratory.
All micewere kept on a 12 h light-dark cycle in a specific-pathogen-free facility with controlled temperature and humidity and had free
access to food and water. For in vivo tail movement test, 7 to 8-week-old male mice were used. All experimental procedures were
conducted according to protocols approved by the directives of the Institutional Animal Care andUseCommittee of Korea Institute of
Science and Technology (KIST, Seoul, Korea).Current Biology 29, 3386–3401.e1–e8, October 21, 2019 e2
Organotypic hippocampal slice culture preparation
Organotypic hippocampal slice culture preparation was performed according to the previous report [9]. Immediately following
decapitation, the brains of 7-day-old Sprague-Dawley rats (DBL, Eumseong, Korea) were removed and soaked in ice cold HBSS
(#14025126, Thermo) with 20 mM HEPES. The frontal cortex and cerebellum were excised, and the hippocampi were isolated
and chopped every 350 mm. Each slice was placed onto a 4.0 mm polytetrafluoroethylene membrane insert (Millicell-CM; Millipore
Co, Darmstadt, Germany) in a six-well plate with 1 mL 50% minimum essential medium (#LM007-60, Welgene Inc, Gyeongsan, Ko-
rea), 25% horse serum (#S104-01, Welgene Inc, Gyeongsan, Korea), 25% HBSS, 6 g/L D-glucose, 1 mM L-glutamine, 20 mM
HEPES, and 1%penicillin-streptomycin (#15140-122, GIBCO) titrated to pH 7.1with NaOH andHCl. Themediumwas changed every
second day, and cultured slices, incubated at 37C in a humidified 5% CO2 incubator, were used after 14 days. All experimental
protocols were reviewed and approved by the Institutional Animal Care and Use Committee of Kyung Hee University
(KHUASP[SE]-15-024).
HEK293T and HEK293T-Piezo1 knockout (HEK-P1KO) cell culture
Human embryonic kidney 293T (HEK293T) cells were purchased from ATCC (RRID: CVCL_0063) and have been tested for myco-
plasma contamination. HEK-P1KO cells (Clone 5E3) were kindly provided by Dr. Patapoutian in the Scripps Research Institute.
HEK293T and HEK-P1KO cells were cultured in DMEM (#10-013, Corning) supplemented with 25 glucose, 4 L-glutamine, 1 sodium
pyruvate (in mM), 10% heat-inactivated fetal bovine serum (#10082-147, GIBCO) and 10,000 units/ml penicillin–streptomycin
(#15140-122, GIBCO). Cells were maintained at 37C in a humidified 5% CO2 incubator. 18 h before experimental day, cells were
transfected with DNA by transfection reagent (Effectene; #301425, QIAGEN). On experiment day, the transfected cells were replated
onto cover-glass for Ca2+ imaging and electrophysiological recordings.
Primary mouse astrocyte culture
Primary cultured astrocytes were prepared from cortex of C57BL/6J mouse pups (P0-P2) as described [45]. The cerebral cortex was
dissected from the brain and adherent meninges were removed, minced and dissociated into single cell suspension by trituration.
Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM; #10-013, Corning) supplemented with 25 glucose, 4 L-gluta-
mine, 1 sodium pyruvate (in mM), 10% heat-inactivated horse serum (#26050-088, GIBCO), 10% heat-inactivated fetal bovine serum
(#10082-147, GIBCO) and 10,000 units/ml penicillin–streptomycin (#15140-122, GIBCO). Cultures were maintained at 37C in a hu-
midified 5% CO2 incubator. On 3 days in vitro (DIV), cells were vigorously washed with repeated pipetting and the media was re-
placed to get rid of debris and other floating cell types. During maintaining the culture before use, the media was replaced every
3-4 days. For gene-silencing experiments with primary cultured astrocytes, various shRNAs were electroporated (Neon Transfection
system kit; #MPK10096, Invitrogen) into trypsinized cultured astrocytes 4 days before experimental day and replated onto culture
dish. One day before the experimental day, cells were replated onto cover-glass coated with 0.1 mg/ml poly D-lysine (PDL,
#P6407, Sigma-Aldrich).
Astrocyte-neuron coculture
For astrocyte-neuron coculture, primary mouse neuron culture was prepared as followed. Embryos from pregnant C57BL/6J mice
(E18.5) were decapitated and the cortices were dissected out and were treated with 2.5% trypsin (#15090-046, GIBCO). Dissociated
cells were seeded onto 12 mm cover-glass coated with PDL. Cells were cultured in plating medium consisting of neurobasal media
supplemented with 5%heat-inactivated fetal bovine serum (#10082-147, GIBCO), 2%B27-supplement (#17504-044, GIBCO), 2mM
Glutamax-I (#35050-061, Thermo) and 10,000 units/ml penicillin-streptomycin (#15140-122, GIBCO). After 7-10 days in culture, pri-
mary cultured astrocytes fromWT or TRPA1 KOmice were plated on top of the cultured cortical neurons. Astrocytes and neurons on
coculture were used for Ca2+ imaging after 2-3 days.
METHOD DETAILS
Tail movement test with ultrasound
Tail movement test with ultrasound was performed according to previous report [79]. Ultrasound was produced by two function gen-
erators connected in series, in which the first function generator (AGF3022B, Tektronix, Oregon, USA) triggered the operation of the
second function generator (33210A, Agilent, CA, USA). The bursts of pulsed sine waves generated from function generators were
amplified by the linear power amplifier (AG 1021, T&C Power Conversion, Inc. NY, USA) and then provided a single-element focused
ultrasound transducer (EofE Ultrasonics Co., Ltd, Gyenggi-do, Korea) with a diameter of 6.5 cm, a geometrical focal length of 7 cm.
Ultrasound was induced with following parameters: 350 kHz fundamental frequency, 1.5 kHz pulse repetition frequency, 0.23 ms
pulse duration, 66.67 ms sonication duration. A custom-made, cone-shaped plastic housing was combined with the ultrasound
transducer and filled with degassed water for transmitting acoustic waves. The distal end of the housing was sealed with a silicone
membrane. TRPA1 KO and Best1 KOmice (male, 8-10 weeks old) were anesthetized by an intraperitoneal (i.p.) injection of ketamine
(50mg/kg bodyweight; Ketamine, YuhanCo., Seoul, Korea) and xylazine (5mg/kg bodyweight; Rompun, Bayer Korea, Seoul, Korea)
mixture. Mouse was positioned on a stereotaxic apparatus (David Kopf Instruments, CA, USA) and lifted by 40 mm to rest the tail on
the floor. The ultrasound transducer was affixed above the mouse head, and the focus of the transducer was positioned to target the
area of motor cortex. The stimulation location was first selected approximately 3.5 mm lateral to the midline and 7.5 mm posterior toe3 Current Biology 29, 3386–3401.e1–e8, October 21, 2019
the rear corner of the mouse’s eyes [80]. Once the motor response was elicited, stimulation location was then carefully adjusted to
achieve the most sensitive site for inducing motor response in each mouse. Motor responses were quantified as a robustness score
of tail movement, which can be easily detected through visual inspection. The scoreswere ranked fromone to three, whichwasmodi-
fied from a previous report [31]. A score of one was considered when the tail was twitched but did not leave the surface of the floor. A
score of twowas assigned less than 1 cm height of tail movement. More than 1 cm height of tail movement was designated as a score
of three.
Multielectrode array recording of LILFU-induced neuronal firing
Multielectrode array (MEA) recording was performed according to the previous report [9]. The 8 3 8 MEA (Multi Channel Systems
GmbH, Reutlingen, Germany) included an amplifier, four-channel stimulus generator and two temperature-control units maintaining
solution and baseplate at 33 Cwithin 0.01 C [81]. TheMEAwas bathed for 1 h in 2% ultrasonol 7 (Carl Roth GmbH, Karlsruhe, Ger-
many), brushed, coated with 0.1% polyethylenimine (PEI; Sigma-Aldrich), and sterilized by UV for at least 3 h. Between experiments,
probes were cleaned with 2% ultrasonol 7 in distilled water for 30 min, then rinsed and kept in room-temperature distilled water. Rat
brain slices were presoaked in artificial cerebrospinal fluid (ACSF) contained 124 NaCl, 26 NaHCO3, 10 glucose, 3 KCl, 2 CaCl2,
1 MgCl2, 10 HEPES (in mM), adjusted to pH 7.4, and centered on the MEA perfused with 3 ml/min flowing ACSF. Slices were stabi-
lized for 1 h at 33 C. Slice and MEA array were transferred onto an MEA1060 amplifier interface (1,200 dB gain) and grounded with
an Ag/AgCl pellet. Sixty channels of data were sampled at 25 kHz and processed in MC_Rack and MC_Data Tool (Multi Channel
Systems, GmbH, Reutlingen, Germany) by desktop computer. For generating LILFU for MEA recording, ultrasound pulser
(MKPR-1025; MKC Korea, Seoul, Korea) and water-immersion transducer (10 3 10 mm square crystal element; TKS Co., Busan,
Korea) centered approximately 5 mm over the MEA in contact with the perfusing ACSF were used. Ultrasound was induced with
following parameters: 500 kHz fundamental frequency, 1.16 kHz pulse repetition frequency, 20.97 ms pulse duration. Parameters
were optimized to yield a spatial peak pressure of 11.52 kPa. MEA signals were detected and analyzed as previously described
[9]. For all MEA recoding, LILFU was applied for 3 min, following a 3 min baseline. The percent of neuronal firing from the baseline
was measured by the number of neuronal firing during 3 min LILFU as a percent of 3 min baseline before LILFU. For blocking
experiment, HC030031 (40 mM, #H4415, Sigma-Aldrich), niflumic acid (100 mM, #N0630, Sigma-Aldrich), NPPB (5-Nitro-2-(3-phenyl-
propylamino)benzoic acid; 100 mM, #N4779, Sigma-Aldrich), AP-5 (50 mM, #0106, Tocris) or kynuranic acid (300 mM, #K3375, Sigma-
Aldrich) was put into the ACSF.
Micromachined ultrasound transducer array for in vitro Ca2+ imaging
Micromachined ultrasound transducer array for in vitro Ca2+ imaging upon LILFU was fabricated according to the previous report
[34]. A piezoelectric micromachined ultrasonic transducer (pMUT) array using a bulk piezoelectric (PZT) film coated with CuNi elec-
trodes on both sides (PIC 151, PI, Germany) was fabricated. The fabrication process starts with a 4-inch silicon-on-insulator (SOI)
wafer and the wafer is bonded with a 1-mm-thick bulk PZT film. As a bonding layer between SOI wafer and bulk PZT film, CYTOP
(CTL-809; AGC, Japan) is spin-coated on both sides of the SOI wafer and the PZT film. Then, they are bonded together in a wafer-
level bonder at the temperature of 160C with an applied pressure of 3.5 kg$f/cm2. Next, the bonded PZT film is thinned down to
40 mmby chemical mechanical polishing (CMP) process. Then, 300-nm-thick platinum and 20-nm-thick chrome layers are deposited
using a sputter and patterned by lift-off process to form top electrodes. To pattern the bulk PZT layer, combination of 150-nm-thick
chrome layer and a 10-mm-thick AZ 9260 photoresist layer as an etch mask was used. The PZT layer is etched in a mixture of
H2O:HCl:HF with a ratio of 250:10:1 until the bottom electrode is exposed. After the bottom electrodes are exposed by the PZT
etching process, a 300-nm-thick gold and 20-nm-thick chrome adhesion layers are deposited and patterned using lift-off process
to provide electrical connections between bottom electrodes and pads. Next, a 100-nm-thick aluminum layer is deposited and
patterned on the backside of the SOI wafer as an etch mask for DRIE process. Finally, the membrane of the transducer is released
by DRIE process by using the 0.7-mm-thick buried oxide layer as an etch stop layer. The top electrodes are isolated while the bottom
electrodes are connected through the silicon substrate to allow for individual control of each element. The fabricated pMUT array was
mounted on a printed circuit board (PCB) and pads on the pMUT array were connected to the pads on the PCB using wire bonding.
The diameter of the single ultrasound transducer is 500 mm, and the resonant frequency of the transducer was measured to be
430 kHz. The acoustic power from a single transducer can be controlled from 10.2 kPa to 67.3 kPa with varying the applied actuation
voltage from 11V to 66 V. In the experiment for Ca2+ imaging in vitro, ultrasound was induced with following parameters: 430 kHz
fundamental frequency, 2 kHz pulse repetition frequency, 0.25 ms pulse duration, 100 ms sonication duration, acoustic power of
67.3 kPa with an applied voltage of 66 V.
TRP gene cloning and shRNA vector construction
Each cDNA encoding full-length mouse TRPA1 (NM_177781.5), mouse TRPC1 (NM_011643.3), mouse TRPV4 (NM_022017.3), or
mouse Piezo1 (NM_001357349.1) were subcloned into pIRES2-EGFP vectors (#6029-1, Addgene) by using XhoI and BamH1 sites.
The mouse TRPA1 nucleotide (NM_177781.5) from 1767 to 1787 (50-gcaagcttcctttctgcatat-30) and the mouse Best1 nucleotides
(NM_011913.2) from 774 to 793 (50-tttgccaacttgtcaatgaa-30) were selected for the target sequence of each TRPA1- and Best1-
shRNA. For making shRNA, two kinds of oligos were purchased (Sequence of oligos; [phos]50-t [sense sequence of target] ttcaagaga
[reverse complement sequence of target] ttttttc-30 and [phos]50-tcgagaaaaaa [sense sequence of target] tctcttgaa [reverse comple-
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4 Mg-acetate (in mM), adjusted pH 7.3 by KOH and incubated at 95C for 5 min and 70C for 10 min. The annealed double-stranded
oligo was inserted into SacII-NotI resctiction sites of pSico (#11578, Addgene) or HpaI-XhoI restriction enzyme sites of pSicoR len-
tiviral vector (#11579, Addgene) [55] and verified by sequencing.
Ca2+ imaging
Cells (HEK293T, HEK-P1KO, astrocyte or astrocyte-neuron coculture) were incubated with 5 mM Fura-2 AM (#F1201, Thermo Fisher
Scientific) mixed with 1 mL of external solution containing 5 mL of 20% pluronic acid (#P3000MP, Thermo Fisher Scientific) for 40 min
at room temperature. External solution contained 150 NaCl, 10 HEPES, 3 KCl, 2 CaCl2, 2 MgCl2, 5.5 glucose (in mM), adjusted to pH
7.3 and osmolarity to 325 mOsmol kg1. Intensity images of 510 nm wavelength were taken at 340 nm and 380 nm excitation wave-
lengths using either iXon EMCCD (DV887DCS-BV, ANDOR technology, Belfast, UK). The two resulting imageswere acquired in Axon
ImagingWorkbench 6.2 (Indec BioSystems, CA, USA) and analyzed in Clampfit 10.4 (Molecular Devices, CA, USA). For Ca2+ imaging
in TRPA1, TRPC1, TRPV4 or Piezo1-transfected HEK293T, each DNA construct was transfected into HEK293T using Effectene
transfection reagent (#301425, QIAGEN). The number of cells showingCa2+ response during 3min LILFUwas calculated as a percent
of responsive cells. The threshold of Ca2+ response was determined by unimodal thresholding [82] calculated by MATLAB (R2010b,
Mathworks). The Ca2+ peak amplitude (ratio) in Ca2+ imaging upon LILFU was measured during 3 min LILFU. Onset time of Ca2+
response in experiment with astrocyte-neuron coculture (Figures 3D–3F) was measured during 5 min after the start time of LILFU.
The Ca2+ peak amplitude (ratio) in Ca2+ imaging upon NMM - (Figures S4C, S4F, and S5C) or poking- (Figure S5I) wasmeasured after
the time of NMM treatment or poking. For blocking experiment, 40 mM HC030031 (#H4415, Sigma-Aldrich) or 50 mM AP-5 (#0106,
Tocris) was put into the external solution. For positive control of TRPA1, 100 mMNMM (N-Methylmaleimide; #389412, Sigma-Aldrich)
was put into the external solution. For depletion of the endoplasmic reticulum Ca2+, 1 mM thapsigargin (#T9033, Sigma-Aldrich) was
put into the external solution.
Indentation (Piezo-electrically driven mechanical stimulation)
Piezo-electrically driven mechanical stimulation was achieved as previously described [38, 39]. A fire-polished glass electrode (tip
diameter: 34 mm) as a probewas positioned at an angle of 50 to the cell surface. Downwardmovement of the probewas controlled
by a micromanipulator (Nano-controller NC4; Kleindiek Nanotechnik, Germany) connected with computer. The initial position of the
probe on the cell surface was determined by looking at the indentation of the cell surface through a microscope. Then, 1.0 mm of
indentation was delivered to the cell surface, which was considered as the initial point of piezo-electrically driven mechanical stim-
ulation. From the initial position, themechanical steps weremade bymoving the probe downward up to 5 mm in 2 mm increments. The
duration of the piezo-electrically driven mechanical stimulation was 600 ms.
Poking
Poking was achieved using poking pipette (4 7 MU) filled with HEPES buffer contained 150 NaCl, 10 HEPES, 3 KCl, 2 CaCl2,
2 MgCl2, 5.5 glucose (in mM), adjusted to pH 7.3 and osmolarity to 325 mOsmol kg
1. For measuring resistance of poking pipette,
Digidata 1322A (Axon Instruments), Axopatch 200A amplifier (Axon Instruments) and pClamp 10.4 software (Molecular Devices) were
used. Cultured astrocyte or HEK293T or HEK-P1KO were monitored by iXon EMCCD (DV887 DCS-BV, ANDOR technology, Belfast,
UK). We recorded not only the resistance of poking pipette determined by the current generated by periodic test pulses of 10 mV at
20 Hz using Clampex 10.4 (Molecular Devices), but also the indentation depth displayed by the MPC-200 micromanipulator (Sutter
Instrument) which has 0.0625 mm resolution.We first moved the poking pipette to the cell membranemanually usingMPC-200micro-
manipulator very slowly.When the poking pipette touched the cell membrane, whichwas the initial point of stimulation, the resistance
of poking pipette started to increase. We then slowly lowered the poking pipette until its resistance increase (DR) reached 3 6 MU
within 20 30 s for HEK293T and HEK-P1KO or 0.2 0.5 MU within 3 5 s for astrocyte, until a large inward current was induced.
Finally, we raised the poking pipette from the cell membrane slowly within 5 10 s. After finishing the recording, the exact DR value
was calculated from the recorded current amplitude of poking pipette.
Whole-cell patch-clamp recording
For fast-exerted indentation-induced current recording, whole-cell patch-clamp recording was performed as previously described
[39]. External solution contained 130 NaCl, 5 KCl, 1 CaCl2, 2MgCl2, 10 HEPES, 10 D-mannitol (in mM), adjusted to pH 7.2 with NaOH.
Currents were recorded from HEK293T or HEK-P1KO under voltage clamp (Vh = 60 mV) using Axopatch 200A amplifier (Axon In-
struments), acquired with pClamp 10.4 (Molecular Devices). Recording pipette (2 3 MU) was filled with 130 CsCl, 2 MgCl2, 10
HEPES, 2 Mg-ATP, 0.2 Na3-GTP, 25 D-mannitol (in mM), adjusted to pH 7.2 with CsOH. Current amplitude at the peak or 600 ms
after indentation was measured. For poking-induced current recording, whole-cell patch-clamp recording was performed.
External solution contained 150 NaCl, 10 HEPES, 3 KCl, 2 CaCl2, 2 MgCl2, 5.5 glucose (in mM), adjusted to pH 7.3 and osmolarity
to 325mOsmol kg1. Currents were recorded from cultured astrocytes or HEK293T or HEK-P1KOunder voltage clamp (Vh =70mV)
using Axopatch 200A amplifier (Axon Instruments), acquired with pClamp 10.4 (Molecular Devices). Recording pipette (47MU) was
filled with 110 Cs-gluconate, 30 CsCl, 0.5 CaCl2, 10 HEPES, 4 Mg-ATP, 0.3 Na3-GTP and 10 BAPTA (in mM), adjusted to pH 7.3 with
CsOH and osmolality to 290-310 mOsmol kg-1 with sucrose. For comparing the poking-induced current, the current amplitude was
measured 5 s after time of poking and analyzed by Clampfit 10.4 (Molecular Devices). For H2O2 scavenger experiment, edaravone
(MCI-186; 10 mM, #ab120645, Abcam) or AAD-2004 (10 mM, GNT Pharma) was put into external solution.e5 Current Biology 29, 3386–3401.e1–e8, October 21, 2019
Cell-attached patch-clamp recording with negative pressure
For single channel current recording with negative pressure, cell-attached patch-clamp recording was performed as previously
described [40]. External solution contained 140 KCl, 10 HEPES, 1 MgCl2, 10 glucose (in mM), adjusted to pH 7.3 with KOH. Currents
were recorded from cultured astrocytes or HEK293T or HEK-P1KO under voltage clamp (Vh = 80 mV) using Axopatch 200A ampli-
fier (Axon Instruments), acquired with pClamp 10.4 (Molecular Devices). Recording pipette (47MU) was filled with 130 NaCl, 5 KCl,
10 HEPES, 1 CaCl2, 1 MgCl2, 10 TEA-Cl, adjusted to pH 7.3 with NaOH. Negative pressure steps (0 -60 mmHg, D10 mmHg) were
exerted via the recording electrode using pressure clamp HSPC-1 device (ALA Scientific Instruments, NY, USA) controlled by Clam-
pex 10.4 (Molecular Devices). The duration of the negative pressure was 500 ms. Current amplitude and open probability (Po) was
measured by Clampfit 10.4 (Molecular Devices) after recording. For blocking TRPA1, 40 mMHC030031 (#H4415, Sigma-Aldrich) was
put into the internal solution of recording pipette.
Sniffer-patch from primary cultured cortical astrocytes
Primary cortical astrocytes were prepared from postnatal day P0P2 of C57BL/6J mice (RRID: IMSR_JAX:000664). One day before
the experiment, HEK293T were transfected with 1:10 ratio of pEGFP-N1 (#6085-1, Clontech) and GluR1-L497Y receptor [45] using
Effectene (#301425, QIAGEN). 50 mM CNQX (#0190, Tocris) was always supplemented in the medium to block the AMPA receptor-
mediated cytotoxicity. On the day of sniffer-patch, HEK293T expressing GluR1-L497Y were dissociated, triturated, added onto the
cover-glass with cultured astrocytes, and then allowed to settle for at least 1 h before sniffer-patching. 50 mMCNQX was also added
to the mixed culture of astrocyte and HEK293T to block the AMPA receptor-mediated cytotoxicity. After HEK293T settled, cultured
astrocytes were incubated with 5 mM Fura-2AM (#F1201, Thermo Fisher Scientific) for 40 min and washed at room temperature and
subsequently transferred to a microscope stage. External solution contained 150 NaCl, 10 HEPES, 3 KCl, 2 CaCl2, 2 MgCl2,
5.5 glucose (in mM), adjusted to pH 7.3 and osmolarity to 325 mOsmol kg1. Intensity images of 510 nm wavelength were taken
at 340 nm and 380 nm excitation wavelengths using iXon EMCCD (DV887 DCS-BV, ANDOR technology, Belfast, UK). The two re-
sulting images were used for ratio calculations in Axon ImagingWorkbench 6.2 (Indec BioSystems). GluR1-L497Y-mediated currents
were recorded from HEK293T under voltage clamp (Vh = 70 mV) using Axopatch 200A amplifier (Axon Instruments), acquired with
pClamp 10.4 (Molecular Devices). Recording pipette (4 7 MU) was filled with 110 Cs-gluconate, 30 CsCl, 0.5 CaCl2, 10 HEPES,
4 Mg-ATP, 0.3 Na3-GTP and 10 BAPTA (in mM), adjusted to pH 7.3 with CsOH and osmolality to 290-310 mOsmol kg
-1 with sucrose.
To normalize different amounts of expression of GluR1-L497Y on the HEK293T, 1 mM of glutamate in the bath was applied to maxi-
mally activate the GluR1-L497Y after current recording. Normalization was then accomplished by dividing the current induced by
glutamate from astrocytes by the current induced by bath application of glutamate. The Ca2+ peak amplitude (ratio) from astrocytes
and peak current amplitude from sensor cells were measured after the time of poking and analyzed by Clampfit 10.4 (Molecular
Devices).
Computational simulation for LILFU- and poking-induced pressure distribution on the surface of astrocyte





where v is the speed of sound and the displacement j is a function of position r
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and one can obtain the harmonic solution of the equation as
jð r!; tÞ = j0
r
cosð2pft kr + fÞ
with a given frequency f and a phase fwhere j0 is a constant and k the wave number defined by 2pf=v, which shows a wave gener-
ated by a point source located at the origin. By the principle of superposition one can assume that the waves generated by point
sources located at arbitrary positions can be the sumof the waves that would have been caused by each stimulus individually. There-
fore, we can obtain a function describing a wave generated by an arbitrary shaped sound source. We have calculated the sound
pressure in the area with a diameter of 100 mm to mimic a typical membrane surface of an astrocyte. The area is 1 mm apart from
a circular ultrasonic transducer with a diameter of 500 mm. We have stimulated point sources located in the transducer area with
the binary phases of 0 and p, which are associated to point sources in arbitrary manner. The result of simulation is obtained by using
Mathematica 11 (Wolfram, USA) as the 3 dimensional pressure distribution on the membrane surface of astrocyte.Current Biology 29, 3386–3401.e1–e8, October 21, 2019 e6
The simulation of themechanical poking onto the surface of an astrocyte is accomplished by pressing a shell structure with a diam-
eter of 100 mm to mimic an astrocyte, by the tip of a rounded rod. The starting geometry of the shell structure is similar to a disk with
rounded edges andwith a negative gradient from the center to the border in the case of the top surface. The height of the disk is set to
1.5 mm. The rod moves down, according to the central normal axis to the top surface of the shell structure, to the half of the central
thickness. The elastic modulus of the shell surface is set to 60 kPa, based on the atomic force microscopic measurement from as-
trocytes [50]. The pressure distribution on the surface of the shell structure was calculated and displayed by Abaqus 2018 (Dassault
Systemes, France).
Electron microscopy
For electron microscopic immunostaining for GFP and TRPA1, three hGFAP-GFP transgenic mice (male, 8-10 weeks old; RRID:
IMSR_JAX:003257) were deeply anesthetized with sodium pentobarbital (80 mg/kg, i.p. injection) and perfused transcardially with
10 mL heparinized normal saline followed by 50 mL freshly prepared mixture of 4% paraformaldehyde and 0.01% glutaraldehyde
in 0.1 M phosphate buffer, pH 7.4. Hippocampus was removed and postfixed in the same fixative for 2 h at 4C. Sections were
cut sagittally on a Vibratome at 60 mm and cryoprotected in 30% sucrose in PB overnight at 4C. Next day, sections were frozen
on dry ice for 20 min, thawed in phosphate-buffered saline (PBS; 0.01 M, pH 7.4) to enhance penetration. They were pretreated
with 1% sodium borohydride for 30 min to quench glutaraldehyde and then blocked with 3% H2O2 for 10 min to suppress endog-
enous peroxidases andwith 10%normal donkey serum (Jackson ImmunoResearch, PA, USA) for 30min. For double immunostaining
for GFP and TRPA1, sections of hippocampus were incubated overnight in a mixture of chicken anti-GFP (1:300, #GFP-1020, Aves
Labs, Oregon, USA) and rabbit anti-TRPA1 [83] (1:80, kindly donated from Prof. Noguchi, Hyogo college of medicine, Japan) anti-
bodies. After rinsing in PBS, sections were incubated with a mixture of biotinylated donkey anti-chicken (1:200, #703-065-155, Jack-
son ImmunoResearch) and 1 nm gold-conjugated donkey anti-rabbit (1:50, #25701, EMS, PA, USA) antibodies for 2 h. The sections
were postfixed with 1% glutaraldehyde in PB for 10 min, rinsed in PB several times, incubated for 4 min with HQ silver enhancement
solution (Nanoprobes, NY, USA), and rinsed in 0.1 M sodium acetate and PB. The sections were then incubated with ExtrAvidin
peroxidase (1:5,000, Sigma-Aldrich) for 1 h and the immunoperoxidase was visualized by nickel-intensified 3,30-diaminobenzidine
tetrahydrochloride (DAB). Sections were further rinsed in PB, osmicated (in 0.5% osmium tetroxide in PB) for 1 h, dehydrated in
graded alcohols, flat-embedded in Durcupan ACM (Fluka, Buchs, Switzerland) between strips of Aclar plastic film (EMS), and cured
for 48 h at 60C. Chips containing prominent staining for GFP and TRPA1 in the hippocampus were cut out of the wafers and glued
onto blank resin blocks with cyanoacrylate. Serially cut thin sections were collected on Formvar-coated single-slot nickel grids and
stained with uranyl acetate and lead citrate. Grids were examined on a Hitachi H 7500 electron microscope (Hitachi, Tokyo, Japan) at
80 kV accelerating voltage. Imageswere capturedwith Digital Montage software driving aMultiScan cooled CCD camera (ES1000W,
Gatan, CA, USA) attached to themicroscope. To control specificity of primary antibodies, sections of CA1were processed according
to the above-described protocols, except that primary or secondary antibodies were omitted. Omission of primary or secondary an-
tibodies completely abolished specific staining. In addition, specificity of the immunoreaction was also confirmed by the consistency
of immunostaining in adjacent serial thin sections of the same astrocytes. For quantitative analysis of TRPA1 expression in different
compartment of astrocyte (soma, process, andmicrodomain), thirty electronmicrographs at 25,000 Xwere taken of all TRPA1+/GFP+
astrocyte within 939 mm2 from one thin sections in each hippocampal CA1 of threemice. Small astrocytic process that is smaller than
0.3 mm in diameter was defined as microdomain. Gold particle that is at the plasma membrane and within 25 nm from it was defined
as membrane-bound gold particle. The density of gold particle for TRPA1 was determined by manual counting of gold particles over
the area of GFP+ profiles: cell nuclei and mitochondria were excluded.
Evaluation of mouse skull effect on ultrasound transmission
Ex vivo mouse skulls were isolated to evaluate the attenuation of ultrasound transmission by measuring acoustic pressure (Fig-
ure S1B). The pressure distribution field was measured in a degassed water tank using a calibrated needle-type hydrophone
(HNR-500, Onda Corporation, CA, USA) attached to a three-axis robotic platform (Bi-Slides, Velmex, NY, USA) moving with
0.5 mm intervals. The skull was located on the end of the transducer housing, and the hydrophone tip was located parallel to the
beam axis with the tip at the geometrical focus of the transducer. The spatial-peak temporal-average intensity was calculated by
using the formula in previous report [84].
Quantitative real-time PCR
Gene silencing with shRNA targeting TRPA1 was tested by quantitative real-time PCR (qRT-PCR). HEK293T were transfected with
1:1 ratio of TRPA1-shRNA tagging with mCherry and TRPA1 tagging with GFP using Effectene transfection reagent (#301425,
QIAGEN). Approximately 3 days after transfection, total RNA was extracted by using RNA isolation kit (RNeasy Mini Kit, #74104,
QIAGEN). cDNA was synthesized by using reverse transcriptase (SuperScript III reverse transcriptase; #18080-044, Invitrogen).
For qRT-PCR, SYBR-green (SYBR Green PCR master mix; #4309155, Applied Biosystems) was used. The following sequences
of primers were used for quantitative real-time PCR. Mouse TRPA1 forward: 50-gcatacccagtcctgacctt-30; Mouse TRPA1 reverse:
50-caatgacgcatgcttctgga-30. Human GAPDH forward: 50-cctgcaccaccaactgctta-30; Human GAPDH reverse: 50-ggccatccacagtctt
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Western blot
Cultured cortical astrocytes transfected with control- or TRPA1-shRNAwere lysed with RIPA buffer (#R4100, GenDEPOT) containing
protease inhibitor cocktail (#P3100, GenDEPOT). 40 mg of obtained protein lysates were separated by protein electrophoresis using
protein gels (#4561084, BIORAD) and blotted onto PVDF membranes (#1704156, BIORAD). The blots were incubated overnight at
4Cwith rabbit anti-TRPA1 (1:500, Abfrontier, Korea) and rabbit anti-actin (1:2000, #A2066, Sigma-Aldrich). Blots were then washed
and incubated with horseradish peroxidase-conjugated donkey anti-rabbit IgG (#NA9340, Amersham), followed by washing and
detection of immunoreactivity with enhanced chemiluminescence (GE Healthcare Life Sciences). The band intensity was acquired
by ImageQuant LAS 4000 (GE Healthcare) and quantified using ImageJ software (NIH).
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are presented as mean ± SEM. For all experiments, data normality was analyzed using a D’Agostino–Pearson omnibus
normality test. Differences between groups were evaluated by unpaired two-tailed t test or one-way ANOVA with Tukey’s multiple
comparisons tests. For data not following normal distribution, a Mann-Whitney test (Two-tailed) or Kruskal–Wallis test with Dunn’s
multiple comparison test were performed. For tail movement test data, two-way ANOVA with Sidak’s multiple comparisons test was
performed for statistical analysis. Data from multiple independent experiments was assumed to be normal variance. p < 0.05 was
considered to indicate statistical significance throughout the study. The significance level is represented as asterisks (*p < 0.05,
**p < 0.01, ***p < 0.001; ns, not significant). Detailed statistical analysis contents are described in Table S1. All data are presented
as mean ± SEM. No statistical method was used to predetermine sample size. Sample sizes were determined empirically based
on our previous experiences or the review of similar experiments in literatures. The numbers of animals used are described in the
corresponding figure legends or on each graph. All experiments were done with at least three biological replicates. Animals were
genotyped before experiments, and they were all caged together and treated in the same way. Animals were randomly and evenly
allocated to each experimental group. To perform the group allocation in a blindedmanner during data collection, animal preparation
and experiments were performed by different investigators. No data point was excluded. GraphPad Prism 7.02 for Windows
(GraphPad Software) was used for these analyses and to create the plots. Additional statistical details are provided in Table S1.
DATA AND CODE AVAILABILITY
This study did not generate code. Means and SEMs are posted here in Table S1.Current Biology 29, 3386–3401.e1–e8, October 21, 2019 e8
